Literature DB >> 4488654

Pharmacokinetic studies of clindamycin phosphate.

R M DeHaan, C M Metzler, D Schellenberg, W D Vandenbosch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4488654     DOI： 10.1002/j.1552-4604.1973.tb00208.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  29 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  The effect of cirrhosis on the disposition and elimination of clindamycin.

Authors:  G R Avant; S Schenker; R H Alford
Journal:  Am J Dig Dis       Date:  1975-03

3.  Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.

Authors:  R F Malacoff; F O Finkelstein; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

4.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

5.  Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.

Authors:  I B Xue; P G Davey; G Phillips
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

6.  Efficacy of intravenous clindamycin and methicillin in gram-positive soft tissue infections.

Authors:  K C Chessick; L A Begley; L E Curtis; E F Hirsch; C W Kaiser; C A Burek; H S Soroff
Journal:  Ann Surg       Date:  1975-02       Impact factor: 12.969

7.  Simple assay for clindamycin in the presence of aminoglycosides.

Authors:  F R Ervin; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

8.  Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens.

Authors:  J F Flaherty; L C Rodondi; B J Guglielmo; J C Fleishaker; R J Townsend; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

9.  Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice.

Authors:  C L Wells; R P Jechorek; M A Maddaus; R L Simmons
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

10.  Clindamycin therapy of experimental Staphylococcus aureus endocarditis.

Authors:  W M Scheld; M L Johnson; E B Gerhardt; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.